In breast cancer, lung cancer, neuroblastoma, ovarian cancer, and hepatocellular carcinoma, studies have confirmed that FAK–Src–Paxillin cascade pathway modulates tumor cell proliferation, migration, and metastasis26,42–45. This evidence concerns the gene PXN and ovarian cancer.